Published in Neth Heart J on December 17, 2010
Fresh arrhythmia news: suitable for daily use? Neth Heart J (2011) 0.75
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Risk stratification in the long-QT syndrome. N Engl J Med (2003) 7.25
Prevalence of the congenital long-QT syndrome. Circulation (2009) 4.32
A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res (2000) 3.68
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA (2005) 3.51
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation (2006) 3.23
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation (2009) 3.11
Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation (2007) 2.88
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm (2009) 2.81
Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol (2009) 2.65
Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J (2006) 2.54
NOS1AP is a genetic modifier of the long-QT syndrome. Circulation (2009) 2.00
Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol (2006) 1.73
The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation (2007) 1.58
Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol (1999) 1.54
Genetics of cardiac arrhythmias. Heart (2005) 1.50
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation (2005) 1.48
Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation (2006) 1.42
Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc (1999) 1.32
Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med (2004) 1.28
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Disease-causing mutations in the human genome. Eur J Pediatr (2000) 1.22
High prevalence of four long QT syndrome founder mutations in the Finnish population. Ann Med (2009) 1.08
Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide. Neth Heart J (2009) 0.96
Of founder populations, long QT syndrome, and destiny. Heart Rhythm (2009) 0.95
Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population. Circ Cardiovasc Genet (2009) 0.89
Clinical and genetic analysis of long QT syndrome in children from six families in Saudi Arabia: are they different? Pediatr Cardiol (2009) 0.78
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79
Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet (2001) 1.79
Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78
Homozygous premature truncation of the HERG protein : the human HERG knockout. Circulation (1999) 1.71
Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67
[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55
Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52
Mutations in the T (brachyury) gene cause a novel syndrome consisting of sacral agenesis, abnormal ossification of the vertebral bodies and a persistent notochordal canal. J Med Genet (2013) 1.51
[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46
The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39
[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39
The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30
Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet (2010) 1.24
Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci U S A (1995) 1.19
The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13
The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol (2009) 1.11
Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene. J Med Genet (2006) 1.10
The crystallin gene families. Ciba Found Symp (1984) 1.01
Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology (2009) 1.00
Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996. Cytogenet Cell Genet (1996) 0.98
Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med (2004) 0.98
Founder mutations in the Netherlands: SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best characterised families worldwide. Neth Heart J (2009) 0.96
Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94
First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94
Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J (2013) 0.94
Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J (2014) 0.93
Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92
Phenotypic discordance upon paternal or maternal transmission of duplications of the 11p15 imprinted regions. Eur J Med Genet (2009) 0.92
Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J (2010) 0.91
The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Neth Heart J (2011) 0.91
Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Neth Heart J (2011) 0.91
Rationale and design of the CAREFUL study : The yield of CARdiogenetic scrEening in First degree relatives of sudden cardiac and UnexpLained death victims <45 years. Neth Heart J (2010) 0.90
Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90
An integrated physical map of 210 markers assigned to the short arm of human chromosome 11. Genomics (1994) 0.89
Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome. Am J Med Genet A (2005) 0.88
Physical mapping of 3 candidate tumor suppressor genes relative to Beckwith-Wiedemann syndrome associated chromosomal breakpoints at 11p15.3. Cytogenet Cell Genet (1995) 0.88
Positional cloning of genes involved in the Beckwith-Wiedemann syndrome, hemihypertrophy, and associated childhood tumors. Med Pediatr Oncol (1996) 0.88
High distress in parents whose children undergo predictive testing for long QT syndrome. Community Genet (2005) 0.87
Isolation and characterization of beta- and gamma-crystallin genes from rat genomic cosmid libraries. Gene (1984) 0.87
Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS). Neth Heart J (2014) 0.87
Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet (2005) 0.85
Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Neth Heart J (2007) 0.84
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers. Neth Heart J (2009) 0.84
Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome. Neth Heart J (2008) 0.83
A young man with near-syncope. Neth Heart J (2011) 0.82
[Probability distribution of population forecasts]. Maandstat Bevolking (1998) 0.82
Netherlands Heart Journal: accepted into PubMed Central! Neth Heart J (2006) 0.81
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy. Neth Heart J (2007) 0.81
GENCOR: a national registry for patients and families suffering from a familial heart disease in the Netherlands. Neth Heart J (2006) 0.81
Letter regarding article by McNair et al, "SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia". Circulation (2005) 0.80
Growth regulation of extraembryonic tissues. The effect of genomic imprinting on development of the placenta. Eur J Obstet Gynecol Reprod Biol (1997) 0.80
Recurrent and founder mutations in inherited cardiac diseases in the Netherlands. Neth Heart J (2009) 0.80
Founder mutations in the Netherlands: familial idiopathic ventricular fibrillation and DPP6. Neth Heart J (2011) 0.80
Biomechanics of the human temporomandibular joint during chewing. J Dent Res (2003) 0.79
Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease. Neth Heart J (2007) 0.79
[Hypertrophic cardiomyopathy: a genetically-carried heart disease]. Ned Tijdschr Geneeskd (2002) 0.79
Genomic imprinting: concept and clinical consequences. Ann Med (1999) 0.79
Genomic organization and chromosomal localization of a member of the MAP kinase phosphatase gene family to human chromosome 11p15.5 and a pseudogene to 10q11.2. Genomics (1997) 0.79
SBDS mutations and isochromosome 7q in a patient with Shwachman-Diamond syndrome: no predisposition to malignant transformation? Cancer Genet Cytogenet (2004) 0.78
Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients. Eur J Cancer (2012) 0.78
T-wave alternans in a patient with long-QT syndrome type 3. Neth Heart J (2006) 0.77
Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters. Neth Heart J (2007) 0.77
Towards a better risk stratification for sudden cardiac death in patients with structural heart disease. Neth Heart J (2009) 0.77
A large family characterised by nocturnal sudden death. Neth Heart J (2002) 0.77
Flush after syncope: not always an arrhythmia. J Cardiovasc Electrophysiol (2006) 0.77
Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS study. Neth Heart J (2011) 0.76
Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study. Int J Androl (1992) 0.76
Non-starch polysaccharides in pig feeding. Vet Q (1998) 0.76
De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome. Clin Genet (2013) 0.76
COMPANION - a friend indeed. Neth Heart J (2003) 0.75
A fainting lady with some extrasystoles. Neth Heart J (2004) 0.75
Clinical significance of a persistent left superior vena cava. Ultrasound Obstet Gynecol (2008) 0.75
Cardiogenetic counselling in a non-university hospital. Neth Heart J (2007) 0.75
Primary ventricular fibrillation in acute myocardial infarction: an inherited disease? Neth Heart J (2001) 0.75
Familial primary arrhythmia syndromes: Nice to know or need to know. Neth Heart J (2002) 0.75
Recent breakthroughs in the genetics of atrial fibrillation. Neth Heart J (2003) 0.75
Nightly phenomena, day time work? Neth Heart J (2004) 0.75
Primary prevention: prime time?: ICD trials (and tribulations). Neth Heart J (2004) 0.75
TDI-echocardiography: a new screening tool for long QT syndrome? Eur J Echocardiogr (2003) 0.75
Case histories: increasing role for major journals. Neth Heart J (2009) 0.75
Diversity in cardiac sodium channel disease phenotype in transgenic mice carrying a single SCN5A mutation. Neth Heart J (2007) 0.75
One more time: bibliometric analysis of scientific output remains complicated. Neth Heart J (2011) 0.75
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 2. Neth Heart J (2004) 0.75
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 1. Neth Heart J (2004) 0.75